Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-28 @ 12:01 AM
Study NCT ID:
NCT01833169
Status:
COMPLETED
Last Update Posted:
2018-10-19
First Post:
2013-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BKM120 for Patients With PI3K-activated Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-05
First Submit QC Date:
None
Study First Post Date:
2013-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-09-26
Results First Submit QC Date:
None
Results First Post Date:
2017-12-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-18
Last Update Post Date:
2018-10-19
Last Update Post Date Type:
ACTUAL